BioHealth News Archive
Jackson Lab Wins $3.2M NIH Grant to Develop Epigenome Modification Tech – GenomeWeb
The Jackson Laboratory has been awarded a $3.2 million grant from the National Institutes of Health to develop an epigenome modification technology for studying…
Read More
PepVax Announces Completion of Efficacy Study with Key Pre-Clinical Data to Validate PVX-009,
PepVax, Inc., an early-stage biotechnology company, announced today that it has successfully completed the efficacy study for its lead candidate, PVX-009. The Company is…
Read More
Novavax veteran lines up as next president of Icon’s ClinicalRM | FierceBiotech
Icon has hired a retired colonel who is moving into the biotech sphere as new president of its subsidiary ClinicalRM. James Cummings, M.D., will lead…
Read More
Precision For Medicine Expands Services In Europe, Announces Next Generation Biomarker Data Management And Translational Informatics Platform
Precision for Medicine, part of Precision Medicine Group, today announced it is expanding its biomarker data management and translational informatics services into Europe. The…
Read More
REGENXBIO and AveXis Announce Expansion of Relationship through Amended License Agreement for the Development and Commercialization of Treatments for Spinal Muscular Atrophy Nasdaq:AVXS
REGENXBIO Inc. (Nasdaq:RGNX) and AveXis, Inc. (Nasdaq:AVXS) today announced that they have entered into an amendment which expands upon the exclusive, worldwide license agreement…
Read More
Qiagen and DiaSorin partner on tuberculosis testing
Qiagen has announced a new partnership with DiaSorin that will allow the companies to offer new automated tuberculosis detection capabilities for their customers. {iframe}https://www.zenopa.com/news/801843584/qiagen-and-diasorin-partner-on-tuberculosis-testing{/iframe}
Read More![Pfizer Halts Drug Research For Alzheimer’s and Parkinson’s Because It’s Too Expensive [Updated]](https://wpdev.biohealthinnovation.org/wp-content/uploads/2014/04/pfizer-logo.png){kind=logo}
Pfizer Halts Drug Research For Alzheimer’s and Parkinson’s Because It’s Too Expensive [Updated]
Pfizer, one of the world’s largest drug companies, announced over the weekend that it would stop work on new drugs to fight Alzheimer’s disease…
Read More
Voluntis and WellDoc Announce Partnership to Combine Diabetes Digital Therapeutic Offerings
Voluntis and WellDoc®, two of the industry’s leading digital therapeutics companies, announced today a commercial agreement aimed at combining Voluntis’ insulin titration technology with…
Read More
A dynamite year for VC – NVCA
Explore the infographic to discover key insights from the upcoming 4Q PitchBook-NVCA Venture Monitor. For a complete analysis of VC activity, sign up to…
Read More
R&D Grants Available for Maryland’s Hi-Tech Entrepreneurs
Grants up to $1 million are available from the US-Israel Bi-national R&D (BIRD) Foundation to support new product development R&D, conducted as a joint…
Read MoreTAI Diagnostics Closes $10M Series A Financing; Partners With United Therapeutics | GenomeWeb
TAI Diagnostics, a developer of diagnostic tests for monitoring the health of transplanted organs, said on Monday that it has closed a $10 million…
Read More
Banner year: Greater Washington venture capital tops $1.5B in 2017 in Pitchbook report – Washington Business Journal
Greater Washington had its second-biggest venture funding year in at least a decade in 2017, with startups across the metro area raking in more…
Read More
Pharma, biotech will repatriate billions thanks to Trump’s tax bill, Alexandria Real Estate chair says | Fox Business
The pharma and biotech industry will send billions of dollars back to the United States as a result of President Donald Trump’s tax overhaul,…
Read More
Alexandria Venture Investments Launches the Alexandria Seed Capital Platform, a Novel and
Alexandria Venture Investments, the strategic venture capital arm of Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT uniquely focused on collaborative…
Read More
Roche, GE to develop digital diagnostics platform – MarketWatch
Roche Holding AG (ROG.EB) said Monday that it has entered into a strategic partnership with GE Healthcare to jointly develop and market a digital…
Read More